BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu R, Zhang M, Liu ZH, Hao M, Tian Y, Li M, Wu FP, Wang WJ, Shi JJ, Zhang X, Jia XL, Jiang ZC, Li XM, Xu GH, Li YP, Dang SS. Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens. World J Gastroenterol 2024; 30(44): 4725-4737 [PMID: 39610775 DOI: 10.3748/wjg.v30.i44.4725]
URL: https://www.wjgnet.com/1007-9327/full/v30/i44/4725.htm
Number Citing Articles
1
Li-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, Lin-Li Xu, Jing Li, Yan Cheng, Li-Jun Zheng, Cun-Wen Wu, Han-Xian Chen, Ze-Ren Chen, Jian-Qi Lian, Shi-Hong Wu, Li-Min Luo, Wei-Lu Zhang, Ye Zhang. Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot studyVirology Journal 2025; 22(1) doi: 10.1186/s12985-025-02761-3
2
Jun Chen, Zebing Huang, Xueyao Yang, Yongwen Yang, Min Tan, Lihua Duan, Xuexuan Li, Shang Gao, Zhiliang Gao, Yan Huang. Predictors of Durable Hepatitis B Surface Antigen Loss After Pegylated Interferon–Based Therapy in Patients with Hepatitis B e Antigen–Negative Chronic Hepatitis B: A Multicenter Real-World StudyThe Journal of Infectious Diseases 2025;  doi: 10.1093/infdis/jiaf198